NM Store roll out, page-19

With October coming up I thought it might be a good time to clear up a few things in relation to Japan and the various  launches.

WED 11 JULY ANNOUNCEMENT

“The évolis@ branded FGF5 inhibitor anti-aging hair products will be launched in Japan in July 2018 (évolis® Professional) and October 2018 (évolis® pharmacy). This is the first time that the Australian manufactured products will be exported to Japan and it follows a period of extensive product testing on Japanese customers assessing both beauty and therapeutic applications. The sales channels for évolis® Professional will be e-commerce and hair salons, while the évolis® pharmacy range will be sold through independent chemists. Both product ranges will be manufactured in Australia.”

OK.
This raises an obvious question or two.
What is being manufactured by Advangen in Japan then?
Just JOJU and Lexilis?
Is this where the lash creators and eyebrow enhancers, if any, are coming from?

Seems an annnouncement should be forthcoming in October with any luck and just before the ¼ result.

Also.
From the US distribution update.
“Events will have some local character; the Ala Moana shopping centre in Hawaii, for example, is a mecca for Japanese tourists. Bilingual staff and brochures will be available to maximise engagement. Neiman Marcus is well known and associated with prestige products for most of the 1.5 million Japanese tourists who visit Hawaii annually, making them the largest group of international travellers to the islands. With the recent Japanese launch of évolis® Professional, customers can make their repeat purchase (of the same stuff ) at home, ONLINE!”

Raises another question or two.
Do the two products Evolis R professional and Evolis R have the same levels of ingredients and therefore become interchangeable?
Can you use a Evolis Professional Reverse Activator with Evolis® Shampoos and  Conditioners for instance?
What is the advantage of having two lines?
I suspect it is to allow additional markets to be formed while maintaining exclusivity for one or the other.
Dunno - bit of a mystery some of this.